Sat.May 25, 2024 - Fri.May 31, 2024

article thumbnail

Mental Health Awareness Month: Reducing the Stigma Starts in Pharmacies

Pharmacy Times

Lenora Newsome, PD, president of the National Association of Boards of Pharmacy, explores how pharmacists can support mental health through private conversations, and educating about prescriptions.

123
123
article thumbnail

Q&A: CVS Pharmacy Technician on Rhode Island Unionization Efforts

Drug Topics

Chris DesRochers, a pharmacy technician who works at a CVS in Wakefield, Rhode Island and is active in the recent organizing, discusses what motivated him and his coworkers to unionize.

212
212
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

NIH documents show how $1.6 billion long Covid initiative has failed so far to meet its goals

STAT

More than three years ago, the National Institutes of Health launched a $1 billion-plus initiative to find the root causes and potential treatments for long Covid , the chronic disease that has quickly changed the lives of millions of Americans. But a lack of visible progress from the initiative, called RECOVER, has drawn months of criticism from patient advocates, researchers, and lawmakers, including at a Senate hearing last week on the NIH’s budget.

article thumbnail

How CVS is betting big on healthcare services 'locally delivered' on a national scale

Fierce Healthcare

WASHINGTON D.C. — CVS Health continues to invest heavily in healthcare delivery services with a focus on affordability, convenience and better access to primary care. | CVS Health continues to make investments in healthcare delivery services with a focus on affordability, convenience and better access to primary care.

134
134
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Study Uncovers Demographic Disparities in Access to AutoHCT Therapy for Patients with Multiple Myeloma

Pharmacy Times

UC Davis Health researchers uncover substantial treatment disparities and inequal access to autologous hematopoietic cell transplantation therapy among multiple myeloma patients.

139
139
article thumbnail

FDA Approves Breyanzi to Treat Relapsed or Refractory Mantle Cell Lymphoma

Drug Topics

The approval of Lisocabtagene maraleucel (Breyanzi; liso-cel) was based on data from the TRANSCEND-NHL-001 study, in which the therapy showed rapid and durable response rates.

FDA 201

More Trending

article thumbnail

COVID-19 vaccinations now ‘alarmingly low’ in Europe

pharmaphorum

COVID-19 vaccination rates have fallen precipitously in Europe and should be ramped up this autumn so they are at least in line with influenza vaccine uptake.

Vaccines 142
article thumbnail

Public Health Matters Video: Suicide Prevention and Reducing Mental Health Stigma

Pharmacy Times

Tune into this special episode of “Public Health Matters” to hear Emma White, the founder and president of the nonprofit organization Life Is Worth It, discuss her mental health journey and how she used it to educate adolescents, teenagers, and young adults on mental wellness.

130
130
article thumbnail

Pharmacist-Provided Care for Common Conditions Could Increase Access, Save Money

Drug Topics

A recent study found that if community pharmacists were utilized to treat common conditions, it could result in significant cost-savings for the health care system.

211
211
article thumbnail

The new menstruation: Girls are getting their periods earlier and less regularly

STAT

Menstruation is a critical indicator of health. Whether and when someone with a uterus gets their period — for the first time, and throughout their life — can reflect not only their reproductive health, but their risk of cardiovascular disease, cancer, miscarriage, and premature death. That also makes menstruation a useful measure of population health.

143
143
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Interview: Has Cybin hit the biggest breakthrough in 40 years to treat psychiatric disorders?

Outsourcing Pharma

In an intriguing interview with Cybinâs CEO, Doug Drysdale, OSP senior editor, Liza Laws found out how second-generation psychedelics could be the biggest breakthrough in psychiatry in 40 years.

133
133
article thumbnail

Study Finds Guidance Is Needed for Health Technology Assessments of Biosimilars

Pharmacy Times

Australia, Québec, and Sweden have defined processes for reimbursements by health technology assessments, but the United States has a low reliance rate.

145
145
article thumbnail

Slideshow: AI in Skin Cancer Awareness Creates New Opportunities for Care

Drug Topics

Research exploring the growing role of artificial intelligence (AI) in health care sheds a light on the potential of the technology to improve skin cancer detection and awareness among patients and health care professionals.

200
200
article thumbnail

The doctor would treat her sickle cell pain crisis — if she promised not to get an abortion

STAT

Here are some things A. was told when she arrived at the hospital one night in June 2023. That she couldn’t have the pain medicine she usually got for a sickle cell crisis because she was six weeks pregnant, but she could have Tylenol. That if she just took her blood thinner everything would be fine. That she needed to leave, and if she still felt bad by the time she’d wheelchaired out into the parking lot, she could turn around and check herself back into the emergency room.

Hospitals 140
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Takeda, amid restructuring campaign, plots 641 layoffs at two Massachusetts sites

Fierce Pharma

A recently announced $900 million restructuring drive is already making waves at Takeda, wi | From early July to March 2025, the Japanese drugmaker will cut 495 staffers at its Cambridge location and 146 in Lexington, Massachusetts. Takeda is the largest life sciences employer in the state.

133
133
article thumbnail

Pharmacy Preceptors Play Key Role in Educating Future Pharmacists

Pharmacy Times

Penelope Murphy discusses the role that preceptors play in mentoring students and new pharmacists to help bridge the gap between classroom learning and real-world practice.

131
131
article thumbnail

Bird Flu Infects Second Human as Outbreak Continues

Drug Topics

While US health officials continue to monitor the outbreak in dairy cattle across the country, a second human recently tested positive after a mutation of the bird flu virus.

198
198
article thumbnail

STAT+: For one rare type of lung cancer, Pfizer pill reduces progression by 81%

STAT

There are a lot of reasons why updated data on Pfizer’s Lorbrena, a treatment for non-small cell lung cancer, might not seem to be a big deal. The results are an update on the clinical trial that resulted in the Food and Drug Administration granting Lorbrena full approval in 2001, so in a sense they are not even that new. For Pfizer investors, Lorbrena isn’t that big a deal, either.

136
136
article thumbnail

UnitedHealth projects shaky Medicaid redetermination aftermath

Fierce Healthcare

UnitedHealth is predicting an upcoming “disturbance” among its Medicaid programs as members continue to disenroll after the COVID-19 public health emergency. | UnitedHealth gave an overview of areas in which the insurer can improve upon, how Medicaid redeterminations will affect the company and thoughts on OptumRx.

Insurance 130
article thumbnail

Study: Third of Individuals With Actinic Keratosis Unaware of Its Cause

Pharmacy Times

Although sun-protective measures have been increasing, the incidence of skin cancer has also increased, suggesting better targeted interventions and patient education are needed.

125
125
article thumbnail

Podcast: How an Independent Pharmacist Incorporated Coffee into His Pharmacy

Drug Topics

In an interview with Chris Schaffner, PharmD, owner of Schaffner Pharmacy and Apothecary Coffee in Sedro-Woolley, Washington, he discussed his unique pharmacy operation with the help of coffee shop revenue.

187
187
article thumbnail

Opinion: The world needs the new pandemic treaty

STAT

At the height of the Covid-19 pandemic, 25 heads of government issued an extraordinary call for a new international treaty for preventing, preparing for, and responding to pandemics. For two years, World Health Organization member states have been negotiating an international agreement scheduled for adoption at the World Health Assembly this month. Yet, late Friday in Geneva, negotiations ground to a halt.

140
140
article thumbnail

BioNTech, flush with $145M from CEPI, looks to expand mRNA vaccine production in Africa

Fierce Pharma

As various efforts to produce next-generation vaccines in Africa are being carried forward by the likes of the World Health Organization (WHO) and the Bill & Melinda Gates Foundation, BioNTech | Under an expansion of the partners’ existing deal, the Coalition for Epidemic Preparedness Innovations (CEPI) is committing up to $145 million to bolster BioNTech’s efforts to establish vaccine R&D and manufacturing capabilities at the German company’s facility in Kigali, Rwanda.

Vaccines 126
article thumbnail

ESI Fees Violate Federal Policy; NCPA Pushes CMS for Clarity, Accountability

Pharmacy Times

Almost half of independent pharmacy owners/managers participating in an NCPA survey said that ESI was the pharmacy benefit manager causing the most financial stress in Medicare Part D.

article thumbnail

Over 30% of American Adults Know Someone Who Died of Drug Overdose

Drug Topics

According to a survey, 18.9% of respondents said that the person they knew who died of a drug overdose was a family member or close friend.

187
187
article thumbnail

STAT+: Gene therapies for deafness dredge up an old question: Do deaf people want a ‘cure’?

STAT

When Yilai Shu was training to be an otolaryngologist in Shanghai, in the mid 2000s, he often met parents with congenitally deaf kids. “They always asked me, ‘Do you have any drugs to treat our kids?’ said Shu, who is hearing and a professor at Fudan University in China. “That’s what really inspired me to think about developing a drug.

138
138
article thumbnail

Short reads, big impact: How genomics is revolutionising cancer research

pharmaphorum

Discover how genomics is transforming cancer research through the study of DNA, RNA, and ctDNA. Learn about the latest breakthroughs in the field in this insightful short read.

126
126
article thumbnail

Once Weekly Efsitora Shows Non-Inferiority in A1c Reductions Compared With Daily Basal Insulin

Pharmacy Times

Topline results of QWINT-2 and QWINT-4 met the primary end point of change in hemoglobin A1c compared to degludec and glargine, respectively, for those with type 2 diabetes.

123
123
article thumbnail

Vaccination Prior to Initial Infection Reduced Risk of Post-COVID Condition

Drug Topics

Researchers addressed the association between COVID-19 vaccination status and incidents of post-COVID condition.

Vaccines 187
article thumbnail

STAT+: Many docs who tweeted product endorsements also took money from manufacturers, analysis shows

STAT

Most physicians who endorsed a prescription drug or medical device on X — formerly known as Twitter — also received payments from the manufacturers of these products, according to a new analysis that highlights ongoing concerns about financial ties between doctors and industry. The study found 26 of 28 physicians, or 93%, received at least one payment, and the average was more than $27,400 for such things as food and beverages, speaking, consulting, or travel.

134
134
article thumbnail

Hospital orgs join cross-industry appeal for FTC to delay noncompete ban implementation

Fierce Healthcare

Hospital lobbies have signed onto a multi-sector letter of 230 industry associations and chambers of commerce urging the Federal Trade Commission to bump the effective date of its ban on employee n | The American Hospital Association and the Federation of American Hospitals are among 230 groups urging the regulator to put the final rule on hold pending legal challenges and "lack of Commission guidance on key pieces" of the ban.

Hospitals 127
article thumbnail

Pharmacists Compare Experiences With Multiple Sclerosis at Large Academic Institutions, Small Private Practices

Pharmacy Times

Although resources were scarce for teams at smaller private practices, the pharmacists all agreed that patient care is always the priority.

article thumbnail

FDA Approves Onyda XR, First and Only Liquid Nonstimulant for ADHD

Drug Topics

The drug will be available in pharmacies during the second half of 2024.

FDA 201
article thumbnail

New obesity drugs are seemingly everywhere. Black Americans feel left out

STAT

STAT teamed up with Word In Black, a network of 10 Black news publishers, to report over the past year on the impact of new weight loss drugs on Black America. Jonathan Gustave was diagnosed with type 2 diabetes last August after decades of struggling with his weight. To help lower his blood sugar levels, his doctor prescribed Ozempic, the diabetes drug that has become wildly popular for its weight loss effects.

Insurance 134